The biotech company said requests for remdesivir overwhelmed its emergency treatment access system. Consequently, it plans to rapidly implement expanded access programs.
The agency also launched in information website about Right to Try, which President Donald Trump signed into law in May.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.